TUESDAY, July 15, 2025 (HealthDay News) — For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), according to a study published online July 9 in Diabetes, Obesity and Metabolism. Jingxuan Wang, M.D., from Peking University People’s Hospital in Beijing, and colleagues conducted a retrospective […]
The post Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment first appeared on Physician’s Weekly.
